These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 9310939
21. Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction. Pène F, Grimaldi D, Zuber B, Sauneuf B, Rousseau C, El Hachem C, Martin C, Belaïdouni N, Balloy V, Mira JP, Chiche JD. J Infect Dis; 2012 Sep 15; 206(6):932-42. PubMed ID: 22782952 [Abstract] [Full Text] [Related]
22. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Schultz MJ, Rijneveld AW, Florquin S, Edwards CK, Dinarello CA, van der Poll T. Am J Physiol Lung Cell Mol Physiol; 2002 Feb 15; 282(2):L285-90. PubMed ID: 11792633 [Abstract] [Full Text] [Related]
23. Inhibition of pulmonary neutrophil trafficking during endotoxemia is dependent on the stimulus for migration. Wagner JG, Driscoll KE, Roth RA. Am J Respir Cell Mol Biol; 1999 Apr 15; 20(4):769-76. PubMed ID: 10101010 [Abstract] [Full Text] [Related]
24. TNF-α is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection. Choi S, Park YS, Koga T, Treloar A, Kim KC. Am J Respir Cell Mol Biol; 2011 Feb 15; 44(2):255-60. PubMed ID: 20448050 [Abstract] [Full Text] [Related]
25. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model. Broquet A, Roquilly A, Jacqueline C, Potel G, Caillon J, Asehnoune K. Crit Care Med; 2014 Jun 15; 42(6):e441-50. PubMed ID: 24732238 [Abstract] [Full Text] [Related]
26. The effects of hyperoxia on pulmonary clearance of Pseudomonas aeruginosa. Dunn MM, Smith LJ. J Infect Dis; 1986 Apr 15; 153(4):676-81. PubMed ID: 3081661 [Abstract] [Full Text] [Related]
29. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection. Wölbeling F, Munder A, Kerber-Momot T, Neumann D, Hennig C, Hansen G, Tümmler B, Baumann U. Immunobiology; 2011 Aug 15; 216(8):901-8. PubMed ID: 21497410 [Abstract] [Full Text] [Related]
30. Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. Amano H, Morimoto K, Senba M, Wang H, Ishida Y, Kumatori A, Yoshimine H, Oishi K, Mukaida N, Nagatake T. J Immunol; 2004 Jan 01; 172(1):398-409. PubMed ID: 14688348 [Abstract] [Full Text] [Related]
32. Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation. Ojielo CI, Cooke K, Mancuso P, Standiford TJ, Olkiewicz KM, Clouthier S, Corrion L, Ballinger MN, Toews GB, Paine R, Moore BB. J Immunol; 2003 Oct 15; 171(8):4416-24. PubMed ID: 14530368 [Abstract] [Full Text] [Related]
33. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Morimoto K, Amano H, Sonoda F, Baba M, Senba M, Yoshimine H, Yamamoto H, Ii T, Oishi K, Nagatake T. Am J Respir Cell Mol Biol; 2001 May 15; 24(5):608-15. PubMed ID: 11350831 [Abstract] [Full Text] [Related]
34. Effects of the beige mutation on respiratory tract infection with Pseudomonas aeruginosa in mice. Tanaka E, Yuba Y, Sato A, Kuze F. Exp Lung Res; 1994 May 15; 20(4):351-66. PubMed ID: 7988496 [Abstract] [Full Text] [Related]
36. [Study on pathogenetic role of myeloperoxidase, tumor necrosis factor alpha, interferon gamma in chronic airway infection with Pseudomonas aeruginosa]. Takeda H. Kansenshogaku Zasshi; 1998 Apr 15; 72(4):395-409. PubMed ID: 9621568 [Abstract] [Full Text] [Related]
37. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Oishi K, Sonoda F, Kobayashi S, Iwagaki A, Nagatake T, Matsushima K, Matsumoto K. Infect Immun; 1994 Oct 15; 62(10):4145-52. PubMed ID: 7927669 [Abstract] [Full Text] [Related]